LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 32

Search options

  1. Article ; Online: Prediction, screening and characterization of novel bioactive tetra-peptide matrikines for skin rejuvenation.

    Jariwala, Nathan / Ozols, Matiss / Eckersley, Alexander / Mambwe, Bezaleel / Watson, Rachel E B / Zeef, Leo / Gilmore, Andrew / Debelle, Laurent / Bell, Mike / Bradley, Eleanor J / Doush, Yegor / Keenan, Amy / Courage, Carole / Leroux, Richard / Peschard, Olivier / Mondon, Philippe / Ringenbach, Caroline / Bernard, Laure / Pitois, Aurelien /
    Sherratt, Michael J

    The British journal of dermatology

    2024  

    Abstract: Background: Extracellular matrices play a critical role in tissue structure and function and aberrant remodelling of these matrices is a hallmark of many age-related diseases. In skin, loss of dermal collagens and disorganisation elastic fibre ... ...

    Abstract Background: Extracellular matrices play a critical role in tissue structure and function and aberrant remodelling of these matrices is a hallmark of many age-related diseases. In skin, loss of dermal collagens and disorganisation elastic fibre components are key features of photo-ageing. Although application of some small matrix-derived peptides to aged skin has been shown to beneficially affect in vitro cell behaviour and, in vivo, molecular architecture and clinical appearance, the discovery of new peptides has lacked a guiding hypothesis.
    Objectives: As endogenous matrix-derived peptides can act as cell-signalling molecules (matrikines), we hypothesised that protease cleavage site prediction could identify novel putative matrikines with beneficial activities for skin composition and structure.
    Methods: Here, we present an in silico (peptide cleavage prediction) to in vitro (proteomic and transcriptomic activity testing in cultured human dermal fibroblasts) to in vivo (short term patch test and longer term split-face clinical study) discovery pipeline, which enables the identification and characterisation of peptides with differential activities.
    Results: Using this pipeline we show that cultured fibroblasts are responsive to all applied peptides but their associated bioactivity is sequence-dependent. Based on bioactivity, toxicity and protein source we further characterised a combination of two novel peptides, GPKG and LSVD, that act in vitro to enhance the transcription of matrix organisation and cell proliferation genes and in vivo, in a short-term patch test, to promote processes associated with epithelial and dermal maintenance and remodelling. Prolonged use of a formulation containing these peptides in a split-face clinical study led to significantly improved measures of crow's feet and firmness in a mixed-ethnicity population.
    Conclusions: We conclude that this approach to peptide discovery and testing can identify new synthetic matrikines, providing insights into biological mechanisms of tissue homeostasis and repair and new pathways to clinical intervention.
    Language English
    Publishing date 2024-02-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1093/bjd/ljae061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: In Vivo Human Single-Chain Fragment Variable Phage Display-Assisted Identification of Galectin-3 as a New Biomarker of Atherosclerosis.

    Hemadou, Audrey / Fontayne, Alexandre / Laroche-Traineau, Jeanny / Ottones, Florence / Mondon, Philippe / Claverol, Stéphane / Ducasse, Éric / Sanchez, Stéphane / Mohamad, Sarah / Lorenzato, Cyril / Duonor-Cerutti, Martine / Clofent-Sanchez, Gisèle / Jacobin-Valat, Marie-Josée

    Journal of the American Heart Association

    2021  Volume 10, Issue 19, Page(s) e016287

    Abstract: Background Atherosclerosis is a complex pathology in which dysfunctional endothelium, activated leucocytes, macrophages, and lipid-laden foam cells are implicated, and in which plaque disruption is driven by many putative actors. This study aimed to ... ...

    Abstract Background Atherosclerosis is a complex pathology in which dysfunctional endothelium, activated leucocytes, macrophages, and lipid-laden foam cells are implicated, and in which plaque disruption is driven by many putative actors. This study aimed to identify accurate targetable biomarkers using new in vivo approaches to propose tools for improved diagnosis and treatment. Methods and Results Human scFv (single-chain fragment variable) selected by in vivo phage display in a rabbit model of atherosclerosis was reformatted as scFv fused to the scFv-Fc (single-chain fragment variable fused to the crystallizable fragment of immunoglobulin G format) antibodies. Their reactivity was tested using flow cytometry and immunoassays, and aorta sections from animal models and human carotid and coronary artery specimens. A pool of atherosclerotic proteins from human endarterectomies was co-immunoprecipitated with the selected scFv-Fc followed by mass spectrometry for target identification. Near-infrared fluorescence imaging was performed in
    MeSH term(s) Animals ; Apolipoproteins E ; Atherosclerosis/diagnosis ; Atherosclerosis/genetics ; Bacteriophages ; Biomarkers ; Galectin 3/genetics ; Humans ; Mice ; Plaque, Atherosclerotic ; Rabbits ; Single-Chain Antibodies/genetics
    Chemical Substances Apolipoproteins E ; Biomarkers ; Galectin 3 ; Single-Chain Antibodies
    Language English
    Publishing date 2021-09-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2653953-6
    ISSN 2047-9980 ; 2047-9980
    ISSN (online) 2047-9980
    ISSN 2047-9980
    DOI 10.1161/JAHA.120.016287
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.

    Jacque, Emilie / Chottin, Claire / Laubreton, Daphné / Nogre, Michel / Ferret, Cécile / de Marcos, Sandrine / Baptista, Linda / Drajac, Carole / Mondon, Philippe / De Romeuf, Christophe / Rameix-Welti, Marie-Anne / Eléouët, Jean-François / Chtourou, Sami / Riffault, Sabine / Perret, Gérald / Descamps, Delphyne

    Frontiers in immunology

    2021  Volume 12, Page(s) 683902

    Abstract: Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk ... ...

    Abstract Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis
    Importance: Respiratory Syncytial Virus (RSV) is the major cause of acute lower respiratory infections in children, and is also recognized as a cause of morbidity in the elderly. There are still no vaccines and no efficient antiviral therapy against this virus. Here, we described an approach of passive immunization with a new class of hyper-enriched anti-RSV immunoglobulins (Ig) manufactured from human normal plasma. This new class of immunoglobulin plasma derived product is generated by an innovative bioprocess, called Ig cracking, which requires a combination of expertise in both plasma derived products and affinity chromatography. The strong efficacy in a small volume of these hyper-enriched anti-RSV IgG to inhibit the viral infection was demonstrated using a mouse model. This new class of immunoglobulin plasma-derived products could be applied to other pathogens to address specific therapeutic needs in the field of infectious diseases or even pandemics, such as COVID-19.
    MeSH term(s) Administration, Intranasal ; Animals ; Antibodies, Viral/administration & dosage ; Antibodies, Viral/immunology ; Antibodies, Viral/isolation & purification ; Disease Models, Animal ; Humans ; Immunization, Passive ; Immunoglobulin G/administration & dosage ; Immunoglobulin G/immunology ; Immunoglobulin G/isolation & purification ; Lung/drug effects ; Lung/virology ; Neutralization Tests ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Virus, Human/immunology ; Turbinates/drug effects ; Turbinates/virology ; Viral Fusion Proteins/immunology ; Virus Replication/drug effects
    Chemical Substances Antibodies, Viral ; F protein, human respiratory syncytial virus ; Immunoglobulin G ; Viral Fusion Proteins
    Language English
    Publishing date 2021-06-07
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.683902
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Evaluation of molecules or extracts modulating seborrhea and its consequences, using normal human culture of sebocytes and keratinocytes, skin explants models and

    Mondon, Philippe / Toso, Roberto Dal / Ringenbach, Caroline / LavaissiÈre, Laurent / Doridot, Emmanuel / Ouvrat, Émilie / Brahimi, Sandra

    Journal of cosmetic science

    2017  Volume 68, Issue 2, Page(s) 183–194

    Abstract: Skin produces sebum through sebocytes. Hyper-seborrhea creates conditions for the development of inflamed cutaneous alterations through bacteria colonization triggering dead cell accumulation and pro-inflammatory mediator release. Study of sebum ... ...

    Abstract Skin produces sebum through sebocytes. Hyper-seborrhea creates conditions for the development of inflamed cutaneous alterations through bacteria colonization triggering dead cell accumulation and pro-inflammatory mediator release. Study of sebum production, its modulation, and its consequences requires complementary
    MeSH term(s) Acne Vulgaris/drug therapy ; Adult ; Cells, Cultured ; Dermatitis, Seborrheic/drug therapy ; Humans ; Keratinocytes/drug effects ; Keratinocytes/physiology ; Lipid Metabolism/drug effects ; Macrophages/drug effects ; Plant Extracts/chemistry ; Plant Extracts/pharmacology ; Plant Extracts/therapeutic use ; Sebum/drug effects ; Skin/cytology ; Skin/drug effects ; Syringa/chemistry ; Tissue Culture Techniques ; Young Adult
    Chemical Substances Plant Extracts
    Language English
    Publishing date 2017-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1435667-3
    ISSN 1525-7886 ; 0037-9832
    ISSN 1525-7886 ; 0037-9832
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile.

    Gujer, Cornelia / Murer, Anita / Müller, Anne / Vanoaica, Danusia / Sutter, Kathrin / Jacque, Emilie / Fournier, Nathalie / Kalchschmidt, Jens / Zbinden, Andrea / Capaul, Riccarda / Dzionek, Andrzej / Mondon, Philippe / Dittmer, Ulf / Münz, Christian

    Blood advances

    2019  Volume 3, Issue 7, Page(s) 1129–1144

    Abstract: Infectious mononucleosis, caused by infection with the human gamma-herpesvirus Epstein-Barr virus (EBV), manifests with one of the strongest ... ...

    Abstract Infectious mononucleosis, caused by infection with the human gamma-herpesvirus Epstein-Barr virus (EBV), manifests with one of the strongest CD8
    MeSH term(s) Animals ; CD8-Positive T-Lymphocytes/pathology ; Cell Proliferation ; Dendritic Cells/immunology ; Epstein-Barr Virus Infections/immunology ; Humans ; Interferon Type I/biosynthesis ; Interferon Type I/pharmacology ; Mice ; Virus Internalization/drug effects ; Virus Replication
    Chemical Substances Interferon Type I
    Language English
    Publishing date 2019-04-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2018025536
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A cytoplasmic protein-protein interaction detection method based on reporter translation.

    Renaut, Laurence / Bouayadi, Khalil / Kharrat, Hakim / Mondon, Philippe

    Analytical biochemistry

    2009  Volume 384, Issue 2, Page(s) 362–364

    Abstract: One approach to drug discovery involves the targeting of abnormal protein-protein interactions that lead to pathology. We present a new technology allowing the detection of such interactions within the cytoplasm in a yeast-based system. The interaction ... ...

    Abstract One approach to drug discovery involves the targeting of abnormal protein-protein interactions that lead to pathology. We present a new technology allowing the detection of such interactions within the cytoplasm in a yeast-based system. The interaction detection is based on the sequestration of a translation termination factor involved in stop codon recognition. This sequestration inhibits the activity of the factor, thereby permitting the translation of a reporter gene harboring a premature stop codon. This novel cytoplasmic protein-protein interaction (CPPI) detection system should prove to be useful in the characterization of proteins as well as in partner identification, interaction mapping, and drug discovery applications.
    MeSH term(s) Cytoplasm/metabolism ; Genes, Reporter/genetics ; Lac Operon/genetics ; Models, Biological ; Peptide Chain Termination, Translational/genetics ; Protein Interaction Mapping/methods ; Saccharomyces cerevisiae/genetics ; Saccharomyces cerevisiae/metabolism
    Language English
    Publishing date 2009-01-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1110-1
    ISSN 1096-0309 ; 0003-2697
    ISSN (online) 1096-0309
    ISSN 0003-2697
    DOI 10.1016/j.ab.2008.10.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.

    Le Clorennec, Christophe / Lazrek, Yassamine / Dubreuil, Olivier / Larbouret, Christel / Poul, Marie-Alix / Mondon, Philippe / Melino, Gerry / Pèlegrin, André / Chardès, Thierry

    Oncotarget

    2016  Volume 7, Issue 24, Page(s) 37013–37029

    Abstract: We characterized the mechanism of action of the neuregulin-non-competitive anti-HER3 therapeutic antibody 9F7-F11 that blocks the PI3K/AKT pathway, leading to cell cycle arrest and apoptosis in vitro and regression of pancreatic and breast cancer in vivo. ...

    Abstract We characterized the mechanism of action of the neuregulin-non-competitive anti-HER3 therapeutic antibody 9F7-F11 that blocks the PI3K/AKT pathway, leading to cell cycle arrest and apoptosis in vitro and regression of pancreatic and breast cancer in vivo. We found that 9F7-F11 induces rapid HER3 down-regulation. Specifically, 9F7-F11-induced HER3 ubiquitination and degradation in pancreatic, breast and prostate cancer cell lines was driven mainly by the itchy E3 ubiquitin ligase (ITCH/AIP4). Overexpression of the ITCH/AIP4 inhibitor N4BP1 or small-interfering RNA-mediated knockdown of ITCH/AIP4 inhibited HER3 ubiquitination/degradation and PI3K/AKT signaling blockade induced by 9F7-F11. Moreover, 9F7-F11-mediated JNK1/2 phosphorylation led to ITCH/AIP4 activation and recruitment to HER3 for receptor ubiquitination and degradation. ITCH/AIP4 activity was activated by the deubiquitinases USP8 and USP9X, as demonstrated by RNA interference. Taken together, our results suggest that 9F7-F11-induced HER3 ubiquitination and degradation in cancer cells mainly occurs through JNK1/2-dependent ITCH/AIP4 activation.
    MeSH term(s) Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal, Murine-Derived/pharmacology ; Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Down-Regulation ; Humans ; MAP Kinase Signaling System/drug effects ; MAP Kinase Signaling System/physiology ; Mitogen-Activated Protein Kinase 8/metabolism ; Mitogen-Activated Protein Kinase 9/metabolism ; Receptor, ErbB-3/antagonists & inhibitors ; Repressor Proteins/drug effects ; Repressor Proteins/metabolism ; Ubiquitin-Protein Ligases/drug effects ; Ubiquitin-Protein Ligases/metabolism ; Ubiquitination
    Chemical Substances 9F7-F11 antibody ; Antibodies, Monoclonal ; Antibodies, Monoclonal, Murine-Derived ; Antineoplastic Agents ; Repressor Proteins ; ITCH protein, human (EC 2.3.2.26) ; Ubiquitin-Protein Ligases (EC 2.3.2.27) ; Mitogen-Activated Protein Kinase 9 (EC 2.7.1.24) ; ERBB3 protein, human (EC 2.7.10.1) ; Receptor, ErbB-3 (EC 2.7.10.1) ; Mitogen-Activated Protein Kinase 8 (EC 2.7.11.24)
    Language English
    Publishing date 2016-06-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.9455
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: TGF-beta-induced early gene-1 overexpression promotes oxidative stress protection and actin cytoskeleton rearrangement in human skin fibroblasts.

    Leduc, Chloe / Sobilo, Lauren / Toumi, Hechmi / Mondon, Philippe / Lespessailles, Eric / Ossant, Fédéric / Kurfurst, Robin / Pichon, Chantal

    Biochimica et biophysica acta

    2016  Volume 1860, Issue 6, Page(s) 1071–1078

    Abstract: Background: Transforming growth factor beta inducible early gene-1 (TIEG-1), a member of the Krüppel-like factor, was identified as a primary response gene for TGF-β. The role of TIEG-1 in skin repair has been mainly addressed in vivo on TIEG-1 null ... ...

    Abstract Background: Transforming growth factor beta inducible early gene-1 (TIEG-1), a member of the Krüppel-like factor, was identified as a primary response gene for TGF-β. The role of TIEG-1 in skin repair has been mainly addressed in vivo on TIEG-1 null mice model and the mechanism remains unexplored.
    Methods: We investigated the modulation of TIEG-1 expression in normal human skin fibroblasts by either down-expressing or overexpressing the gene. We evaluated reactive oxygen species production and the cell viability of treated cells. The effect of TIEG-1 overexpression was monitored by wound healing assay and immunofluorescence staining of actin fibers organization and alpha-smooth muscle actin (α-SMA). Western blots were carried out to identify the level of expression or phosphorylation of key proteins such as cofilin, Rho GTPases, and p38 mitogen-activated protein kinase (p38 MAPK).
    Results: TIEG-1 down-regulation had a deleterious effect on the cell viability. It was significantly reduced (65±5%) and exposure to ultraviolet further increased this effect (47±3%). By contrast, cells overexpressing TIEG-1 had a reduced reactive oxygen species production (75%) compared to control and mock-transfected cells. This overexpression also resulted in formation of actin stress fibers and increased α-SMA expression and an enhanced wound healing feature. RhoB GTPase was upregulated and phosphorylation of cofilin and p38 MAPK was observed.
    Conclusion: TIEG-1 overexpression in normal human skin fibroblasts results in improved resistance to oxidative stress, myofibroblast-like conversion that involved RhoB signaling pathway with cofilin and p38 MAPK proteins activation.
    General significance: This study enlightens the role of TIEG-1 role in skin biology.
    MeSH term(s) Actin Cytoskeleton/chemistry ; Actin Depolymerizing Factors/metabolism ; Cell Movement ; Cells, Cultured ; Early Growth Response Transcription Factors/physiology ; Fibroblasts/metabolism ; Humans ; Kruppel-Like Transcription Factors/physiology ; Oxidative Stress ; Phosphorylation ; Skin/cytology ; Wound Healing ; p38 Mitogen-Activated Protein Kinases/metabolism
    Chemical Substances Actin Depolymerizing Factors ; Early Growth Response Transcription Factors ; KLF10 protein, human ; Kruppel-Like Transcription Factors ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2016-06
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 60-7
    ISSN 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650
    ISSN 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbagen.2016.02.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Human antibody libraries: a race to engineer and explore a larger diversity.

    Mondon, Philippe / Dubreuil, Olivier / Bouayadi, Khalil / Kharrat, Hakim

    Frontiers in bioscience : a journal and virtual library

    2008  Volume 13, Page(s) 1117–1129

    Abstract: Several recombinant antibody libraries associated with different screening technologies have been generated since the first steps of antibody engineering 15 years ago, in order to isolate human monoclonal antibodies. In this race to isolate antibody with ...

    Abstract Several recombinant antibody libraries associated with different screening technologies have been generated since the first steps of antibody engineering 15 years ago, in order to isolate human monoclonal antibodies. In this race to isolate antibody with virtually any specificity, innovative strategies have been developed to clone natural antibody repertoires or to increase library diversity beyond the scope of the immune system. After the in vitro transfer of the natural diversity, the second generation of partly or completely man-designed libraries was based on the available structural data of the antibody binding. Efficient selection strategies have proven critical in exploiting the potential of a library's diversity. The development and improvement of screening methods such as phage display, yeast display, ribosome display and robotic platforms have provided innovative tools to efficiently screen and sort out the desired binding specificities of billions of antibodies. Efforts to improve diversity exploration have been mainly focused on screening conditions of display techniques and the new emerging techniques. Here we review some of these prominent approaches in the field of human recombinant antibody libraries.
    MeSH term(s) Animals ; Antibodies, Monoclonal/chemistry ; Antibody Affinity ; Binding Sites, Antibody ; Biochemistry/methods ; Fungal Proteins/chemistry ; Humans ; Hybridomas/metabolism ; Immune System/pathology ; Immunoglobulin Fab Fragments ; Peptide Library ; Protein Engineering/methods ; Ribosomes/chemistry
    Chemical Substances Antibodies, Monoclonal ; Fungal Proteins ; Immunoglobulin Fab Fragments ; Peptide Library
    Language English
    Publishing date 2008-01-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2141320-4
    ISSN 1093-9946
    ISSN 1093-9946
    DOI 10.2741/2749
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The Dual Targeting of FcRn and FcγRs

    Monnet, Céline / Jacque, Emilie / de Romeuf, Christophe / Fontayne, Alexandre / Abache, Toufik / Fournier, Nathalie / Dupont, Gilles / Derache, Delphine / Engrand, Anais / Bauduin, Aurélie / Terrier, Aurélie / Seifert, Alexander / Beghin, Cécile / Longue, Alain / Masiello, Nicholas / Danino, Laetitia / Nogre, Michel / Raia, Anais / Dhainaut, Frederic /
    Fauconnier, Louis / Togbe, Dieudonnée / Reitinger, Carmen / Nimmerjahn, Falk / Stevens, Wil / Chtourou, Sami / Mondon, Philippe

    Frontiers in immunology

    2021  Volume 12, Page(s) 728322

    Abstract: Novel molecules that directly target the neonatal Fc receptor (FcRn) and/or Fc gamma receptors (FcγRs) are emerging as promising treatments for immunoglobulin G (IgG)-dependent autoimmune pathologies. Mutated Fc regions and monoclonal antibodies that ... ...

    Abstract Novel molecules that directly target the neonatal Fc receptor (FcRn) and/or Fc gamma receptors (FcγRs) are emerging as promising treatments for immunoglobulin G (IgG)-dependent autoimmune pathologies. Mutated Fc regions and monoclonal antibodies that target FcRn are currently in clinical development and hold promise for reducing the levels of circulating IgG. Additionally, engineered structures containing multimeric Fc regions allow the dual targeting of FcRn and FcγRs; however, their tolerance needs to first be validated in phase I clinical studies. Here, for the first time, we have developed a modified monomeric recombinant Fc optimized for binding to all FcRns and FcγRs without the drawback of possible tolerance associated with FcγR cross-linking. A rational approach using Fc engineering allowed the selection of LFBD192, an Fc with a combination of six mutations that exhibits improved binding to human FcRn and FcγR as well as mouse FcRn and FcγRIV. The potency of LFBD192 was compared with that of intravenous immunoglobulin (IVIg), an FcRn blocker (Fc-MST-HN), and a trimeric Fc that blocks FcRn and/or immune complex-mediated cell activation through FcγR without triggering an immune reaction in several
    MeSH term(s) Animals ; Antirheumatic Agents/metabolism ; Antirheumatic Agents/pharmacology ; Arthritis, Experimental/genetics ; Arthritis, Experimental/immunology ; Arthritis, Experimental/metabolism ; Arthritis, Experimental/prevention & control ; Autoimmunity/drug effects ; Binding, Competitive ; Complement C5a/metabolism ; Female ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Histocompatibility Antigens Class I/metabolism ; Humans ; Immunoglobulin Fc Fragments/genetics ; Immunoglobulin Fc Fragments/immunology ; Immunoglobulin Fc Fragments/metabolism ; Immunoglobulin Fc Fragments/pharmacology ; Interleukin-2/metabolism ; Jurkat Cells ; Kinetics ; Mice, Inbred C57BL ; Mice, Transgenic ; Mutation ; Phagocytosis/drug effects ; Platelet Aggregation/drug effects ; Protein Binding ; Protein Engineering ; Receptors, Fc/antagonists & inhibitors ; Receptors, Fc/genetics ; Receptors, Fc/immunology ; Receptors, Fc/metabolism ; Receptors, IgG/antagonists & inhibitors ; Receptors, IgG/genetics ; Receptors, IgG/immunology ; Receptors, IgG/metabolism ; Secretory Pathway ; Signal Transduction ; THP-1 Cells ; Mice
    Chemical Substances Antirheumatic Agents ; Histocompatibility Antigens Class I ; IL2 protein, human ; Immunoglobulin Fc Fragments ; Interleukin-2 ; Receptors, Fc ; Receptors, IgG ; Complement C5a (80295-54-1) ; Fc receptor, neonatal (TW3XAW0RCY)
    Language English
    Publishing date 2021-08-26
    Publishing country Switzerland
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.728322
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top